Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 2 1

Status

Recruiting 3Completed 3Active not recruiting 3Terminated 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 28Gynecologic 6Gastrointestinal 6Other solid neoplasm 5Tumor-Agnostic 3CNS 3Thoracic 2Sarcoma 2Plasma cell 2Lymphoid 2Genitourinary 2Other hematologic neoplasm 1Head & Neck 1Dermatologic 1

Conditions

Recurrence 1Medulloblastoma 1Glioblastoma 1Brain Neoplasms 1

Interventions

Temozolomide 79Magnetic Resonance Spectroscopy 68Specimen Handling 45Radiotherapy 42Bevacizumab 29Radiosurgery 27Cyclophosphamide 27Radiation 20pembrolizumab 19Blood Specimen Collection 19fludarabine 16Nivolumab 16Irinotecan 15Carboplatin 13Biopsy 13Etoposide 12Vincristine 11Pemetrexed 11Lomustine 11dinutuximab 9Surgical Procedures, Operative 9trametinib 8abemaciclib 8Ipilimumab 8naxitamab 7fluciclovine F-18 7Watchful Waiting 7Topotecan 7Proton Therapy 7Magnetic Resonance Imaging 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × palbociclib × CNS × Clear all
NCT02896335 2026-03-12

Palbociclib and Pembrolizumab In Central Nervous System Metastases

Massachusetts General Hospital

Phase 2 Recruiting
45 enrolled
CNS

Brain Neoplasms

NCT06959979 2025-05-07

Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase EARLY_PHASE1 Recruiting
60 enrolled
CNS

Medulloblastoma

NCT05432518 2025-04-25

Pilot Trial for Treatment of Recurrent Glioblastoma

AHS Cancer Control Alberta

Phase EARLY_PHASE1 Recruiting
10 enrolled
CNS

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡